Led by GenHenn Venture Fund I, Xenocor will leverage the capital to facilitate launch and rapid adoption of the 5mm articulating Saberscope Xenocor is facilitating the evolution of the 35-year-old MIS ...
An innovative and open solution bringing together multiple observation modes for future-proof endoscopic surgery TOKYO--(BUSINESS WIRE)--Olympus Corporation (“Olympus” - Director, Representative ...
BOSTON--(BUSINESS WIRE)--New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received ...
Dr. Daryl Marx was still in the early stages of his career as a surgeon when he noticed the benefits of less invasive procedures. Laparoscopic surgeries were becoming more prevalent, allowing doctors ...
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback